- 24 h
- letzte 200 News
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| 11.12.25 | Pfizer's cost-cutting drive reaches Switzerland, where company plans to lay off hundreds by year-end: Bloomberg | ||
| 10.12.25 | FTC claims a win as Teva moves to delist hundreds of patents from FDA Orange Book, agency says | ||
| 10.12.25 | CDMO Adare plots 137 layoffs in Philly shortly after transplanting headquarters from N.J. | ||
| 10.12.25 | AstraZeneca-, Gilead-backed program reduced side effects, distress in Black breast cancer patients: study | ||
| 10.12.25 | FDA awards 1st national priority nod to USAntibiotics' Augmentin XR | ||
| 10.12.25 | In win for pharma, UK cuts medicine rebate rate following US intervention | ||
| 10.12.25 | FDA finalizes guidance on promotional materials for biologics and biosimilars | ||
| 10.12.25 | Italian nonprofit lands FDA approval for first gene therapy to treat rare genetic disease | ||
| 10.12.25 | After deal spree, Supreme Group unites agencies to form new PR and communications group | ||
| 09.12.25 | CDMOs Bora, Corealis link up to provide one-stop shop for oral solid dose production, development | ||
| 09.12.25 | Genentech uncovers 'Hidden GeMS' in latest iteration of multiple sclerosis visibility drive | ||
| 09.12.25 | Roll Tide: Lilly selects Alabama site as location for $6B API facility | ||
| 09.12.25 | Biocon buys out Viatris and others from biosimilar subsidiary | ||
| 09.12.25 | FDA now has Merck, AstraZeneca and Sanofi RSV shots for infants in its crosshairs: Reuters | ||
| 09.12.25 | Biosecure legislation makes way into key US defense bill, teeing up potential China biopharma constraints in '26 | ||
| 09.12.25 | With eye on AI, Imre hires Nadine Lafond from Ogilvy Health to fill CEO vacancy | ||
| 09.12.25 | Its future still in limbo, CSL Seqirus debuts $1B flu shot, antivenom plant in Australia | ||
| 08.12.25 | Meds from Pfizer, Lilly, J&J and more secure spots in China's 1st private insurance formulary | ||
| 08.12.25 | Fast-rising UCB set to file for Fintepla approval in 3rd epileptic disorder after trial win | ||
| 08.12.25 | Amgen inks LA sports, entertainment partnership, setting up 2026 World Cup presence | ||
| 05.12.25 | Lowering FDA fees would spur generics manufacturing in US, Mark Cuban says | ||
| 05.12.25 | CDC's ACIP votes to change long-standing hepatitis B vaccine guidance for newborns, prompting backlash | ||
| 05.12.25 | AbbVie revs up Skyrizi spending to top TV ad totals in November, edging out J&J's Tremfya | ||
| 05.12.25 | The biopharma dealmaking landscape and what to expect in 2026 | ||
| 05.12.25 | BMS scores 5th indication for Breyanzi with FDA marginal zone lymphoma nod |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .